pembrolizumab
merck
['bet', ' cana ', ' aca ', 'hodgkin', ' gus ', 'nhl', '2018', 'lymphoma', 'pembro', 'arca, (-arcade)']
#ash22 presents her investigator initiated phase 2 trial pembro+rt in r/r lbcl. well tolerated with orr 32% in highly pretreated population 
Lymphoma/Cellular Therapy & SCT at MD Anderson Cancer Center, opinions/tweets shared= my own.